RMTI Files Form 8-K Furnishing Quarterly Results and XBRL Exhibit

Rhea-AI Filing Summary

Rockwell Medical, Inc. furnished a press release announcing its financial results for the quarter ended June 30, 2025, and attached that press release as Exhibit 99.1 to this Current Report on Form 8-K. The company explicitly states the information in Item 2.02 and Exhibit 99.1 is being furnished and therefore is not deemed "filed" for purposes of Section 18 of the Exchange Act and will not be incorporated by reference into Securities Act filings except by specific reference. Item 9.01 lists the furnished exhibits: Exhibit 99.1 (press release) and Exhibit 104 (Cover Page Interactive Data File in Inline XBRL). The report is signed on behalf of the registrant by Mark Strobeck, Chief Executive Officer.

Insights

Financial Analyst

TL;DR Routine Form 8-K furnished an earnings press release; the filing contains no financial figures.

This Form 8-K serves to furnish the company's quarter-end results press release rather than present financial data within the filing itself. Because the company designates the release and Item 2.02 information as "furnished," they are not asserting the heightened legal status that comes with "filed" disclosures under Section 18. For investors and analysts, the actionable content will be in the press release (Exhibit 99.1) and any Inline XBRL exhibits; the 8-K itself is procedural and therefore has a neutral immediate impact.

Corporate Governance Expert

TL;DR This is a procedural disclosure confirming the company furnished its quarterly results and attached the associated exhibits.

The filing documents standard disclosure practice: the company furnished a press release reporting quarterly results and included the required exhibits, including an Inline XBRL cover page. The Form 8-K emphasizes that the release is "furnished" (not "filed"), which limits incorporation by reference risk. The signature by the CEO certifies the submission on behalf of the registrant. From a governance and compliance perspective, the filing appears to follow routine SEC disclosure procedures without revealing substantive new information in the 8-K text itself.

0001041024FALSE00010410242025-08-142025-08-14

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  August 14, 2025

ROCKWELL MEDICAL, INC.

(Exact name of registrant as specified in its charter)

Delaware			000-23661			38-3317208
(State or other jurisdiction of incorporation)			(Commission File Number)			(IRS Employer Identification No.)

30142 S. Wixom Road, Wixom, Michigan 48393

(Address of principal executive offices, including zip code)

(248) 960-9009

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol

Name of Each exchange on which registered

Common Stock, par value $0.0001

RMTI

Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02        Results of Operations and Financial Condition.

On August 14, 2025 Rockwell Medical, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2025. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

As provided in General Instruction B.2 of Form 8-K, the information in this Item 2.02 and Exhibit 99.1 incorporated in this Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01        Financial Statements and Exhibits.

(d) Exhibits        The following exhibit is being furnished herewith:

EXHIBIT INDEX

Exhibit No.						Description
99.1						Press release dated August 14, 2025
104						Cover Page Interactive Data File, formatted in INline XBRL and included as Exhibit 101.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			ROCKWELL MEDICAL, INC.
Date: August 14, 2025			By:			/s/ Mark Strobeck
						Mark Strobeck
						Chief Executive Officer

FAQ

What did Rockwell Medical (RMTI) disclose in this Form 8-K?

The company furnished a press release announcing financial results for the quarter ended June 30, 2025, and attached it as Exhibit 99.1.

Is the press release in the 8-K considered "filed" with the SEC?

No. The Form 8-K states the information in Item 2.02 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.

Which exhibits were included with the filing?

The filing lists Exhibit 99.1 (press release dated August 14, 2025) and Exhibit 104 (Cover Page Interactive Data File in Inline XBRL).

Who signed the Form 8-K for Rockwell Medical?

The Form 8-K was signed on behalf of the registrant by Mark Strobeck, Chief Executive Officer.

Does the 8-K itself include financial tables or results?

No. The 8-K states a press release with financial results was furnished as an exhibit, but the Form 8-K text does not include financial tables or detailed results.